1.12 USD
↗ 0.01 (0.45%)LIVE (AS OF 02:46 PM EDT)
HCW Biologics Inc. Common Stock
HCWBNASDAQ • USD
Market: OPEN
HCW Biologics Inc. Common Stock (HCWB) trades at $1.12 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, HCWB appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 24, 2026.
Open?$1.09
High?$1.17
Low?$1.06
Prev. Close?$1.11
Volume?190.2K
Avg. Volume?25.0M
VWAP?$1.14
Rel. Volume?0.01x
Bid / Ask
Bid?$1.11 × 100
Ask?$1.29 × 100
Spread?$0.18
Midpoint?$1.20
Valuation & Ratios
Market Cap?7.9M
Shares Out?7.2M
Float?6.1M
Float %?90.7%
P/E Ratio?N/A
P/B Ratio?1.38
EPS?-$2.53
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
Employees
35
Market Cap
7.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-07-20
Address
2929 N COMMERCE PKWY
MIRAMAR, FL 33025
Phone: 954-842-2024
MIRAMAR, FL 33025
Phone: 954-842-2024
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?0
Momentum?90
Short Sent.?71
Piotroski F-Score?6/9Mixed
Altman Z-Score?-6.68Distress
Confidence?46%Low
Short InterestElevated
Short % of Float?6.85%Elevated
Short Interest?418.0K
Days to Cover?1.0
Free Float6.1M
Avg Daily Volume32.6M
Settlement Date2026-05-29
Financial Health
Current Ratio?0.09Weak
Quick Ratio?0.09Weak
Cash Ratio?0.06Low
Debt/Equity?1.14Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.38CHEAP▾
Peers100
S&P90
P/S?1.21CHEAP▾
Peers100
S&P83
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
S&P97
EV/Sales?2.02CHEAP▾
Peers100
S&P74
Returns & Efficiency
ROE?-314.4%WEAK▾
S&P3
ROA?-66.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$13.3M
Fundamentals ratios updated end of day